Posts by Kristina Forbes
Quorum X Diagnostics Inc., (QXD) is awaiting FDA Emergency Use Authorization for its 4-minute At-Home COVID Antigen Test called COVIDNOW®
Tucker, GA— April 17, 2021 —Quorum X Diagnostics, Inc. (QXD) has announced that it is awaiting Emergency Use Authorization (EUA) approval by the U.S. FDA for the first, 4-minute at-home COVID antigen test named COVIDNOW®. This test is available without prescription. “We have every confidence that our EUA will be approved,” said CEO and Co-founder, Dr. Maria M. Nagy, “we…
Read MoreIn Q&A, Vice President Harris calls for urgent action on the Black maternal health crisis
It’s an American crisis that was long ignored at the government’s highest levels: Black women in the U.S. are roughly three times more likely to die giving birth than white women. Now, breaking new ground for a vice president, Kamala Harris is calling for sweeping action to curb racial inequities in pregnancy and childbirth. “With every day…
Read MoreCVS, Walgreens begin rolling out over-the-counter COVID tests from Abbott, Ellume and more
CVS Pharmacy has begun stocking its virtual and in-store shelves nationwide with rapid tests for COVID-19—which can be purchased without a prescription and used by anyone regardless of whether or not they are showing symptoms—including three FDA-authorized diagnostics and sample collection kits produced by LabCorp, Ellume and Abbott. Ellume was one of the first companies…
Read MoreHalf of US adults have received at least one COVID-19 shot
WASHINGTON (AP) — Half of all adults in the U.S. have received at least one COVID-19 shot, the government announced Sunday, marking another milestone in the nation’s largest-ever vaccination campaign but leaving more work to do to convince skeptical Americans to roll up their sleeves. Almost 130 million people 18 or older have received at…
Read MoreApple launches new smartwatch study to detect COVID-19 early, especially in at-risk groups
Hey Siri, can the Apple Watch predict someone’s risk of contracting COVID-19? Apple has launched a study to determine just that. The Apple Respiratory Study will rely on the wearable’s optical heart sensor and self-reported weekly surveys to uncover patterns among participants who end up catching COVID, the flu and other viral infections. The study—led…
Read MoreUS setting up $1.7B national network to track virus variants
WASHINGTON (AP) — The U.S. is setting up a $1.7 billion national network to identify and track worrisome coronavirus mutations whose spread could trigger another pandemic wave, the Biden administration announced Friday. White House officials unveiled a strategy that features three components: a major funding boost for the Centers for Disease Control and Prevention and state health…
Read MoreBlood Clots More Likely After Covid-19 Than After Vaccination, Study Finds
Review by Oxford shows risk of rare, serious blood clotting is eight to 10 times greater in people who caught the coronavirus than among people who received any of the first three Western-developed vaccines A study by the University of Oxford found the risk of rare but sometimes-deadly blood clotting is roughly eight to 10…
Read MorePfizer CEO says third Covid vaccine dose likely needed within 12 months
Pfizer CEO Albert Bourla said people will “likely” need a booster dose of a Covid-19 vaccine within 12 months of getting fully vaccinated. His comments were made public Thursday but were taped April 1. Bourla said it’s possible people will need to get vaccinated against the coronavirus annually. “A likely scenario is that there will be likely a…
Read MoreSherry Farrugia Selected by GCMI Board of Directors as Permanent CEO
Sherry Farrugia has been selected by the Global Center for Medical Innovation (GCMI) board of directors as the organization’s permanent CEO, effective April 1, 2021. Farrugia had been serving as interim CEO for GCMI, a Georgia Tech affiliate, since September 2020. “We are so pleased to congratulate Sherry as she joins GCMI in this permanent…
Read MoreUGA to establish national NIH-funded center to fight flu
The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research (CIDER). The contract will provide $1 million in first-year funding and is expected to be supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, for seven years and…
Read More